osimertinib,gefitinib
astrazeneca
['gefitinib', 'lung', 'osimertinib']
platinum-doublet chemotherapy did not extend survival for patients with advanced nonsquamous non-small cell lung cancer who responded to egfr tyrosine kinase inhibitor therapy. #asco23 #gefitinib #osimertinib 
The content you need, when you need it.